GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Revenio Group Oyj (FRA:R0V) » Definitions » Price-to-Owner-Earnings

Revenio Group Oyj (FRA:R0V) Price-to-Owner-Earnings : 32.78 (As of May. 10, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Revenio Group Oyj Price-to-Owner-Earnings?

As of today (2024-05-10), Revenio Group Oyj's share price is €26.88. Revenio Group Oyj's Owner Earnings per Share (TTM) ended in Mar. 2024 was €0.82. It's Price-to-Owner-Earnings for today is 32.78.


The historical rank and industry rank for Revenio Group Oyj's Price-to-Owner-Earnings or its related term are showing as below:

FRA:R0V' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 22.02   Med: 40.16   Max: 162.27
Current: 32.4

During the past 13 years, the highest Price-to-Owner-Earnings of Revenio Group Oyj was 162.27. The lowest was 22.02. And the median was 40.16.


FRA:R0V's Price-to-Owner-Earnings is ranked better than
51.09% of 276 companies
in the Medical Devices & Instruments industry
Industry Median: 33.015 vs FRA:R0V: 32.40

As of today (2024-05-10), Revenio Group Oyj's share price is €26.88. Revenio Group Oyj's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €0.70. Therefore, Revenio Group Oyj's PE Ratio for today is 38.57.

As of today (2024-05-10), Revenio Group Oyj's share price is €26.88. Revenio Group Oyj's EPS without NRI for the trailing twelve months (TTM) ended in was €0.70. Therefore, Revenio Group Oyj's PE Ratio without NRI for today is 38.57.

During the past 13 years, Revenio Group Oyj's highest PE Ratio without NRI was 118.85. The lowest was 14.37. And the median was 44.99.


Revenio Group Oyj Price-to-Owner-Earnings Historical Data

The historical data trend for Revenio Group Oyj's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revenio Group Oyj Price-to-Owner-Earnings Chart

Revenio Group Oyj Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 79.84 58.20 36.86 38.87

Revenio Group Oyj Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.70 33.89 23.49 38.87 30.40

Competitive Comparison of Revenio Group Oyj's Price-to-Owner-Earnings

For the Medical Devices subindustry, Revenio Group Oyj's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Revenio Group Oyj's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Revenio Group Oyj's Price-to-Owner-Earnings falls into.



Revenio Group Oyj Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Revenio Group Oyj's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=26.88/0.82
=32.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Revenio Group Oyj  (FRA:R0V) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Revenio Group Oyj Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Revenio Group Oyj's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Revenio Group Oyj (FRA:R0V) Business Description

Traded in Other Exchanges
Address
Ayritie 22, Vantaa, FIN, 01510
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.

Revenio Group Oyj (FRA:R0V) Headlines

No Headlines